Home › NDC Lookup › RxCUI directory › RxCUI 308973

Carbamazepine 100 MG Chewable Tablet — RxCUI 308973

RxNorm drug concept · Semantic clinical drug
RxCUI 308973 Semantic clinical drug · SCD ● Current RxNorm concept 17 FDA products 30 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308973
Official nameCarbamazepine 100 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped17
Package NDCs mapped30
Reported Medicaid activity (SDUD)76,546 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Carbamazepine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats certain seizures in epilepsy and the severe facial nerve pain of trigeminal neuralgia. The brand Equetro is also used for manic or mixed episodes in bipolar I disorder. I...
  • Take it by mouth exactly as prescribed. Many forms are taken with meals, and extended-release forms are usually twice a day. Carbatrol and Equetro capsules can be opened onto soft...
  • Dizziness, drowsiness, unsteadiness, nausea and vomiting are most common, especially at the start. Be careful driving until you know how it affects you. Call your doctor if they do...
  • Call for any rash, blisters or mouth sores, especially with fever. Also report fever, sore throat, easy bruising or bleeding, yellow skin or eyes, swelling of the face or lips, or...
📖 Read our full Carbamazepine guide →

🕸️ Concept Web — How Carbamazepine 100 MG Chewable Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carbamazepine 100 MG Chewable Tablet RxCUI 308973

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Carbamazepine 2002
  2. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carbamazepine Chewable Tablet 371257
    • Carbamazepine Chewable Product 1295651
    • Carbamazepine Oral Product 1155760
    • Carbamazepine Pill 1155761
    • Chewable Tablet 91058
    • Chewable Product 1294716
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Carbamazepine 100 MG 315563

Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carbamazepine 100 MG SCDC · 315563
  • Carbamazepine Chewable Tablet SCDF · 371257
  • Carbamazepine Chewable Product SCDG · 1295651
  • Carbamazepine Oral Product SCDG · 1155760
  • Carbamazepine Pill SCDG · 1155761

📦 FDA Products & Package NDCs

17 products · 30 package NDCs
30 package NDCs map to RxCUI 308973 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-0109-10 1000 TABLET in 1 BOTTLE (0093-0109-10) Carbamazepine Teva Pharmaceuticals USA, Inc. 1990-09-30
00615-8125-39 30 TABLET, CHEWABLE in 1 BLISTER PACK (0615-8125-39) Carbamazepine NCS HealthCare of KY, LLC dba Vangard Labs 2019-06-06
00904-3854-61 100 BLISTER PACK in 1 CARTON (0904-3854-61) / 1 TABLET, CHE... CARBAMAZEPINE Major Pharmaceuticals 2010-03-22
00904-6172-50 2000 TABLET in 1 BOTTLE (0904-6172-50) CARBAMAZEPINE Major Pharmaceuticals 2010-09-20
00904-6172-61 100 BLISTER PACK in 1 CARTON (0904-6172-61) / 1 TABLET in 1... CARBAMAZEPINE Major Pharmaceuticals 2010-09-20
51672-4005-01 100 TABLET in 1 BOTTLE (51672-4005-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 1996-10-03
51672-4005-02 500 TABLET in 1 BOTTLE (51672-4005-2) Carbamazepine Sun Pharmaceutical Industries, Inc. 1996-10-03
51672-4005-03 1000 TABLET in 1 BOTTLE (51672-4005-3) Carbamazepine Sun Pharmaceutical Industries, Inc. 1996-10-03
51672-4041-00 10 BLISTER PACK in 1 CARTON (51672-4041-0) / 10 TABLET, CHE... Carbamazepine Sun Pharmaceutical Industries, Inc. 2000-10-24
51672-4041-01 100 TABLET, CHEWABLE in 1 BOTTLE (51672-4041-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2000-10-24
51672-4041-02 500 TABLET, CHEWABLE in 1 BOTTLE (51672-4041-2) Carbamazepine Sun Pharmaceutical Industries, Inc. 2000-10-24
51672-4041-09 5 BLISTER PACK in 1 CARTON (51672-4041-9) / 10 TABLET, CHEW... Carbamazepine Sun Pharmaceutical Industries, Inc. 2000-10-24
51672-4047-04 1 BOTTLE in 1 CARTON (51672-4047-4) / 450 mL in 1 BOTTLE Carbamazepine Sun Pharmaceutical Industries, Inc. 2025-08-15
51672-4050-01 100 TABLET, CHEWABLE in 1 BOTTLE (51672-4050-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2024-03-20
51672-4123-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4123-03 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-3) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4123-06 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4123-6) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4124-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4124-03 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-3) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4124-06 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4124-6) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4125-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-1) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4125-03 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-3) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
51672-4125-06 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4125-6) Carbamazepine Sun Pharmaceutical Industries, Inc. 2009-03-31
60429-0934-05 500 TABLET, CHEWABLE in 1 BOTTLE (60429-934-05) Carbamazepine Golden State Medical Supply, Inc. 2011-07-20
60687-0479-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-479-01) / 1 TAB... Carbamazepine American Health Packaging 2020-01-03
67046-0753-03 30 TABLET, CHEWABLE in 1 BLISTER PACK (67046-0753-3) CARBAMAZEPINE Coupler LLC 2026-06-16
70518-1433-00 30 TABLET, CHEWABLE in 1 BLISTER PACK (70518-1433-0) Carbamazepine REMEDYREPACK INC. 2018-09-24
70518-2426-00 100 POUCH in 1 BOX (70518-2426-0) / 1 TABLET, CHEWABLE in 1... Carbamazepine REMEDYREPACK INC. 2019-11-18
72162-2572-01 100 TABLET, CHEWABLE in 1 BOTTLE (72162-2572-1) CARBAMAZEPINE Bryant Ranch Prepack 2025-11-17
72162-2572-05 500 TABLET, CHEWABLE in 1 BOTTLE (72162-2572-5) CARBAMAZEPINE Bryant Ranch Prepack 2025-11-17
Observed labelers: Sun Pharmaceutical Industries, Inc. (18) · Major Pharmaceuticals (3) · Bryant Ranch Prepack (2) · REMEDYREPACK INC. (2) · American Health Packaging (1) · Coupler LLC (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.